61 related articles for article (PubMed ID: 17329255)
1. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes.
Dehennaut V; Lefebvre T; Sellier C; Leroy Y; Gross B; Walker S; Cacan R; Michalski JC; Vilain JP; Bodart JF
J Biol Chem; 2007 Apr; 282(17):12527-36. PubMed ID: 17329255
[TBL] [Abstract][Full Text] [Related]
2. Induction of maturation-promoting factor during Xenopus oocyte maturation uncouples Ca(2+) store depletion from store-operated Ca(2+) entry.
Machaca K; Haun S
J Cell Biol; 2002 Jan; 156(1):75-85. PubMed ID: 11781335
[TBL] [Abstract][Full Text] [Related]
3. Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent.
Zou L; Zhu-Mauldin X; Marchase RB; Paterson AJ; Liu J; Yang Q; Chatham JC
J Biol Chem; 2012 Oct; 287(41):34419-31. PubMed ID: 22908225
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Inhibitors of O-GlcNAc Transferase That Act In Vivo Implicate Decreased O-GlcNAc Levels in Leptin-Mediated Nutrient Sensing.
Liu TW; Zandberg WF; Gloster TM; Deng L; Murray KD; Shan X; Vocadlo DJ
Angew Chem Int Ed Engl; 2018 Jun; 57(26):7644-7648. PubMed ID: 29756380
[TBL] [Abstract][Full Text] [Related]
5. Heterocyclic aminoparthenolide derivatives modulate G(2)-M cell cycle progression during Xenopus oocyte maturation.
Janganati V; Penthala NR; Cragle CE; MacNicol AM; Crooks PA
Bioorg Med Chem Lett; 2014 Apr; 24(8):1963-7. PubMed ID: 24656611
[TBL] [Abstract][Full Text] [Related]
6. Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells.
Gloster TM; Zandberg WF; Heinonen JE; Shen DL; Deng L; Vocadlo DJ
Nat Chem Biol; 2011 Mar; 7(3):174-81. PubMed ID: 21258330
[TBL] [Abstract][Full Text] [Related]
7. Protein O-GlcNAcylation: emerging mechanisms and functions.
Yang X; Qian K
Nat Rev Mol Cell Biol; 2017 Jul; 18(7):452-465. PubMed ID: 28488703
[TBL] [Abstract][Full Text] [Related]
8. Integrated Glycosylation Patterns of Glycoproteins and DNA Methylation Landscapes in Mammalian Oogenesis and Preimplantation Embryo Development.
Wang J; Tian GG; Li X; Sun Y; Cheng L; Li Y; Shen Y; Chen X; Tang W; Tao S; Wu J
Front Cell Dev Biol; 2020; 8():555. PubMed ID: 32754589
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Sulfide Impairs Meiosis Resumption in
Gelaude A; Slaby S; Cailliau K; Marin M; Lescuyer-Rousseau A; Molinaro C; Nevoral J; Kučerová-Chrpová V; Sedmikova M; Petr J; Martoriati A; Bodart JF
Cells; 2020 Jan; 9(1):. PubMed ID: 31963573
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification.
Nagy T; Fisi V; Frank D; Kátai E; Nagy Z; Miseta A
Cells; 2019 Aug; 8(9):. PubMed ID: 31466420
[TBL] [Abstract][Full Text] [Related]
11.
Fisi V; Kátai E; Orbán J; Dossena S; Miseta A; Nagy T
Molecules; 2018 May; 23(6):. PubMed ID: 29861440
[No Abstract] [Full Text] [Related]
12. O-GlcNAc cycling in the developing, adult and geriatric brain.
Lagerlöf O
J Bioenerg Biomembr; 2018 Jun; 50(3):241-261. PubMed ID: 29790000
[TBL] [Abstract][Full Text] [Related]
13. The Role of Stress-Induced O-GlcNAc Protein Modification in the Regulation of Membrane Transport.
Fisi V; Miseta A; Nagy T
Oxid Med Cell Longev; 2017; 2017():1308692. PubMed ID: 29456783
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of
Luanpitpong S; Chanthra N; Janan M; Poohadsuan J; Samart P; U-Pratya Y; Rojanasakul Y; Issaragrisil S
Mol Cancer Ther; 2018 Feb; 17(2):484-496. PubMed ID: 29167312
[TBL] [Abstract][Full Text] [Related]
15. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc transferase regulates transcriptional activity of human Oct4.
Constable S; Lim JM; Vaidyanathan K; Wells L
Glycobiology; 2017 Oct; 27(10):927-937. PubMed ID: 28922739
[TBL] [Abstract][Full Text] [Related]
17. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches.
Wong CC; Qian Y; Yu J
Oncogene; 2017 Jun; 36(24):3359-3374. PubMed ID: 28092669
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy.
Cheng YU; Li H; Li J; Li J; Gao Y; Liu B
Oncol Lett; 2016 Jul; 12(1):572-578. PubMed ID: 27347182
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation Antagonizes Phosphorylation of CDH1 (CDC20 Homologue 1).
Tian J; Geng Q; Ding Y; Liao J; Dong MQ; Xu X; Li J
J Biol Chem; 2016 Jun; 291(23):12136-44. PubMed ID: 27080259
[TBL] [Abstract][Full Text] [Related]
20. Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects.
Lanza C; Tan EP; Zhang Z; Machacek M; Brinker AE; Azuma M; Slawson C
Cell Cycle; 2016 May; 15(10):1363-75. PubMed ID: 27070276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
